266 related articles for article (PubMed ID: 23040277)
1. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.
Maródi L; Cypowyj S; Tóth B; Chernyshova L; Puel A; Casanova JL
J Allergy Clin Immunol; 2012 Nov; 130(5):1019-27. PubMed ID: 23040277
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.
Rösler B; Wang X; Keating ST; Joosten LAB; Netea MG; van de Veerdonk FL
Clin Exp Immunol; 2018 Nov; 194(2):205-219. PubMed ID: 30069986
[TBL] [Abstract][Full Text] [Related]
3. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
[TBL] [Abstract][Full Text] [Related]
4. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
[TBL] [Abstract][Full Text] [Related]
5. Inborn errors of human JAKs and STATs.
Casanova JL; Holland SM; Notarangelo LD
Immunity; 2012 Apr; 36(4):515-28. PubMed ID: 22520845
[TBL] [Abstract][Full Text] [Related]
6. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.
Smeekens SP; Huttenhower C; Riza A; van de Veerdonk FL; Zeeuwen PL; Schalkwijk J; van der Meer JW; Xavier RJ; Netea MG; Gevers D
J Innate Immun; 2014; 6(3):253-62. PubMed ID: 23796786
[TBL] [Abstract][Full Text] [Related]
7. IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies.
Mogensen TH
Front Immunol; 2018; 9():3047. PubMed ID: 30671054
[TBL] [Abstract][Full Text] [Related]
8. Dysregulatory syndromes: the role of signal transducers and activators of transcription.
Bezrodnik L; Gaillard MI; Caldirola MS
Curr Opin Pediatr; 2018 Dec; 30(6):821-828. PubMed ID: 30407975
[TBL] [Abstract][Full Text] [Related]
9. Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.
Lilly EA; Ikeh M; Nash EE; Fidel PL; Noverr MC
mBio; 2018 Jan; 9(1):. PubMed ID: 29339423
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
Kisand K; Peterson P
Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
[TBL] [Abstract][Full Text] [Related]
11. New perspectives on the immunology of chronic mucocutaneous candidiasis.
Lilic D
Curr Opin Infect Dis; 2002 Apr; 15(2):143-7. PubMed ID: 11964914
[TBL] [Abstract][Full Text] [Related]
12. IL-17 and infections.
Ling Y; Puel A
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():34-40. PubMed ID: 25398490
[TBL] [Abstract][Full Text] [Related]
13. STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases.
Lorenzini T; Dotta L; Giacomelli M; Vairo D; Badolato R
J Leukoc Biol; 2017 Jan; 101(1):29-38. PubMed ID: 27803128
[TBL] [Abstract][Full Text] [Related]
14. Trained Innate Immunity Induced by Vaccination with Low-Virulence
Lilly EA; Bender BE; Esher Righi S; Fidel PL; Noverr MC
mBio; 2021 Oct; 12(5):e0254821. PubMed ID: 34663098
[TBL] [Abstract][Full Text] [Related]
15. The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.
Soltész B; Tóth B; Sarkadi AK; Erdős M; Maródi L
Int Rev Immunol; 2015; 34(4):348-63. PubMed ID: 26154078
[TBL] [Abstract][Full Text] [Related]
16. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects.
Engelhardt KR; Grimbacher B
J Allergy Clin Immunol; 2012 Feb; 129(2):294-305; quiz 306-7. PubMed ID: 22284928
[TBL] [Abstract][Full Text] [Related]
17. Human genetic susceptibility to Candida infections.
Plantinga TS; Johnson MD; Scott WK; Joosten LA; van der Meer JW; Perfect JR; Kullberg BJ; Netea MG
Med Mycol; 2012 Nov; 50(8):785-94. PubMed ID: 22662758
[TBL] [Abstract][Full Text] [Related]
18. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.
Break TJ; Oikonomou V; Dutzan N; Desai JV; Swidergall M; Freiwald T; Chauss D; Harrison OJ; Alejo J; Williams DW; Pittaluga S; Lee CR; Bouladoux N; Swamydas M; Hoffman KW; Greenwell-Wild T; Bruno VM; Rosen LB; Lwin W; Renteria A; Pontejo SM; Shannon JP; Myles IA; Olbrich P; Ferré EMN; Schmitt M; Martin D; ; Barber DL; Solis NV; Notarangelo LD; Serreze DV; Matsumoto M; Hickman HD; Murphy PM; Anderson MS; Lim JK; Holland SM; Filler SG; Afzali B; Belkaid Y; Moutsopoulos NM; Lionakis MS
Science; 2021 Jan; 371(6526):. PubMed ID: 33446526
[TBL] [Abstract][Full Text] [Related]
19. Chronic mucocutaneous candidiasis.
Kirkpatrick CH
Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):448-56. PubMed ID: 2502409
[TBL] [Abstract][Full Text] [Related]
20. [CMCD: Chronic Mucocutaneous Candidiasis Disease].
Okada S
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):109-117. PubMed ID: 28603201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
